论文部分内容阅读
目的探讨联合利福平注射液和参麦注射液治疗肺结核患者的近期效果。方法 120例肺结核患者随机分为观察组和对照组。对照组采用2HZES/6HRE方案行抗结核治疗。观察组则联合利福平注射液和参麦注射液治疗肺结核。记录两组患者一个月后的治疗效果、痰菌转阴情况和不良反应。结果观察组的治疗效果明显优于对照组的治疗效果(P<0.05)。观察组的痰菌阴转率高于对照组(P<0.05)。而观察组的不良反应发生率低于对照组患者(P<0.05)。结论联合使用利福平注射液和参麦注射液治疗肺结核患者,近期效果更好,副作用更少。
Objective To explore the short-term effect of combined rifampin injection and Shenmai injection in the treatment of pulmonary tuberculosis patients. Methods 120 cases of tuberculosis patients were randomly divided into observation group and control group. Control group with 2HZES / 6HRE program for anti-TB treatment. The observation group was combined with rifampin injection and Shenmai injection in the treatment of pulmonary tuberculosis. Record the treatment effect of the two groups of patients after one month, sputum negative conversion and adverse reactions. Results The therapeutic effect of the observation group was significantly better than that of the control group (P <0.05). Observation group sputum negative conversion rate was higher than the control group (P <0.05). The incidence of adverse reactions in the observation group was lower than that in the control group (P <0.05). Conclusion The combination of rifampicin and Shenmai injection in the treatment of patients with pulmonary tuberculosis, the recent effect is better, with fewer side effects.